Judy Muller-Cohn

Scientist, Entrepreneur, Environmentalist

[Judy Muller-Cohn @MullerCohn]

@MKBHD Nice to have it available in apple products.

[Judy Muller-Cohn @MullerCohn]

@cleinad Thanks! Kickin’ it for women entrepreneurs

[Judy Muller-Cohn @MullerCohn]

#womenowned

[Judy Muller-Cohn @MullerCohn]

#WomensHistoryMonth Mobile Xpress Clinics, women making history with Covid testing, a business built in the pandemic for the pandemic.

[Judy Muller-Cohn @MullerCohn]

We want to bring mobile testing and other medical services to the underserved. We would use funding to incorporate more tests and vaccinations for those in need.

[Judy Muller-Cohn @MullerCohn]

My company, Mobile Xpress Clinics a #womenowned company, founded in a pandemic for a pandemic. We’re an aggregator offering Covid tests bringing the tests to businesses. We hired from Second Chance, helping ex-felons get back to work. #TheProfit #lemonaidfoundation @marcuslemonis

[Judy Muller-Cohn @MullerCohn]

We want to bring mobile testing and other medical services to the underserved. We would use funding to incorporate more tests and vaccinations for those in need.

[Judy Muller-Cohn @MullerCohn]

My company, Mobile Xpress Clinics a #womenowned company, founded in a pandemic for a pandemic. We’re an aggregator offering Covid tests bringing the tests to businesses. We hired from Second Chance, helping ex-felons get back to work. #TheProfit #lemonaidfoundation @marcuslemonis

[Judy Muller-Cohn @MullerCohn]

@elonmusk Pcr tests that identify 2 or more genes represent great accuracy if the sample is correctly taken. Infectivity over time remains an issue. As this virus can be so deadly, caution is warranted.

[Judy Muller-Cohn @MullerCohn]

Rolf Muller, CEO BioFluidica presents at MIT Forum

[Judy Muller-Cohn @MullerCohn]

#blood_pac

[Judy Muller-Cohn @MullerCohn]

https://t.co/VauEBNSHnZ

[Judy Muller-Cohn @MullerCohn]

Biofluidica highlighted today in the San Diego Union Tribune. We are on our way to making liquid biopsy a reality.

[Judy Muller-Cohn @MullerCohn]

#BioFluidica CEO Rolf Muller presents platform for capturing circulating tumor & leukemia cells.

[Judy Muller-Cohn @MullerCohn]

#Bahrain